Russian model treatment of pediatric Hematology-Oncology recognized as unique in the world

The world health organization (who) recognized the expertise of Russian children oncologists priority and requested that the model treat pediatric Hematology-Oncology in the CIS countries. In 2017 for the protocols modified by doctors from Russia, began to treat in many countries. This was Continue reading “Russian model treatment of pediatric Hematology-Oncology recognized as unique in the world”

Experts EMA not recommended for women with uterine fibroids to begin therapy with ulipristal

The Committee for risk assessment in the field of pharmacovigilance (PRAC) of the European Agency of medicines (EMA) conducts a risk-benefit analysis of the use of the drug has ulipristal after reports of serious liver damage, including liver failure leading to transplantation.

At the time of Continue reading “Experts EMA not recommended for women with uterine fibroids to begin therapy with ulipristal”